Enhanced bioavailability of a new class of dopamine D-1 antagonists following oral administration of their carbamic acid ester prodrugs to dogs
- 1 February 1992
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 79 (1-3) , 205-212
- https://doi.org/10.1016/0378-5173(92)90112-f
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Carbamate Ester Prodrugs of Dopaminergic Compounds: Synthesis, Stability, and BioconversionJournal of Pharmaceutical Sciences, 1991
- Naltrexone-3-salicylate (a Prodrug of Naltrexone): Synthesis and Pharmacokinetics in DogsPharmaceutical Research, 1988
- Prodrugs for Improved Oral β-Estradiol BioavailabilityPharmaceutical Research, 1988
- Prodrugs for improved oral nalbuphine bioavailability: inter-species differences in the disposition of nalbuphine and its acetylsalicylate and anthranilate estersInternational Journal of Pharmaceutics, 1987
- Improvement of the Oral Bioavailability of Naltrexone in Dogs: A Prodrug ApproachJournal of Pharmaceutical Sciences, 1987
- Analysis of basic compounds on a silica column with an aqueous methanol eluentJournal of Chromatography A, 1987
- Boric acid single dose pharmacokinetics after intravenous administration to manArchives of Toxicology, 1984
- New Lipophilic Terbutaline Ester Prodrugs with Long Effect DurationPharmaceutical Research, 1984
- Separation of organic amine compounds on silica gel with reversed-phase eluentsAnalytical Chemistry, 1982
- Drug Metabolism by the Gastrointestinal MucosaClinical Pharmacokinetics, 1981